Screening for rheumatic heart disease in Aboriginal and Torres Strait Islander children

Journal of Paediatrics and Child Health

Volumn 49, Issue 7, 2013, Pages 526-531

  Rémond, Marc Gerard Wootton ^a   Wark, Emma Kathleen ^a   Maguire, Graeme Paul ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Aborigines; Australian; echocardiography; prophylaxis; rheumatic heart disease; screening

Indexed keywords

ABORIGINE; AUSTRALIA; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEALTH CARE DELIVERY; HEALTH SERVICE; HEART DISEASE; HUMAN; LABORATORY DIAGNOSIS; MASS SCREENING; MEDICAL HISTORY; NEWBORN SCREENING; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION;

ABORIGINES; AUSTRALIAN; ECHOCARDIOGRAPHY; PROPHYLAXIS; RHEUMATIC HEART DISEASE; SCREENING;

AUSTRALIA; CHILD; ECHOCARDIOGRAPHY; HEALTH SERVICES, INDIGENOUS; HUMANS; MASS SCREENING; OCEANIC ANCESTRY GROUP; RHEUMATIC HEART DISEASE;

EID: 84880195509     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12215     Document Type: Review

References (49)

1. Australian Institute of Health and Welfare, Field B,. Rheumatic Heart Disease: All but Forgotten Except among Aboriginal and Torres Strait Islander Peoples. Canberra: AIHW, 2004.
2. Baskerville CA, Hanrahan BB, Burke AJ, Holwell AJ, Remond MG, Maguire GP,. Infective endocarditis and rheumatic heart disease in the north of Australia. Heart Lung Circ. 2012; 21: 36-41.
3. Carapetis JR, Currie BJ,. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in Aboriginal people. Aust. N. Z. J. Public Health 1999; 23: 159-163.
4. Carapetis JR, Zuhlke LJ,. Global research priorities in rheumatic fever and rheumatic heart disease. Ann. Pediatr. Cardiol. 2011; 4: 4-12.
5. Manyemba J, Mayosi BM,. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. 2002; 3: CD002227.
6. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 2007; 357: 470-476.
7. Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5: 411-417.
8. Reeves BM, Kado J, Brook M,. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J. Paediatr. Child Health 2011; 47: 473-478.
9. Webb RH, Wilson NJ, Lennon DR, et al. Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiol. Young 2011; 21: 436-443.
10. Durojaiye OC,. Health screening: is it always worth doing? Internet J. Epidemiol. 2009; 7. Available from: http://archive.ispub.com/journal/%20the- internet-journal-of-epidemiology/volume-7-number-1/%20health-screening-is-it- always-worth-doing.html#sthash.52SjGJxZ.dpuf [accessed 20 November 2011].
11. Peters TJ, Wildschut HIJ, Weiner CP,. Epidemiologic considerations in screening. In:, Wildschut HIJ, Weiner CP, Peters TJ, eds. When to Screen in Obstetrics and Gynaecology. London: WB Saunders, 1996; 1-14.
12. Poikolainen K,. Doing good, doing harm: adverse effects of screening and health education in perspective. Ann. Med. 1992; 24: 425-426.
13. Council of Europe, Committee of Ministers. Recommendation no. R(94)11 on screening as a tool of preventative medicine, 1994.
14. Wilson J, Jungner G,. Principles and practice of screening for disease. Public health paper, number 34. Geneva: World Health Organization, 1968.
15. Australian Health Ministers' Advisory Council. Population Based Screening Framework. Canberra: Commonwealth of Australia, 2008
16. Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Report of A WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease 29 October-1 November 2001. Geneva: World Health Organization, 2001.
17. Carapetis JR, McDonald M, Wilson NJ,. Acute rheumatic fever. Lancet 2005; 366: 155-168.
18. Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull. World Health Organ. 1981; 59: 285-294.
19. Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilario MO,. Resource utilization and cost of rheumatic fever. J. Rheumatol. 2001; 28: 1394-1397.
20. McCallum AH,. Natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a co-operative clinical trial of A.C.T.H., cortisone, and aspirin. Br. Med. J. 1965; 2: 607-613.
21. Ralph A, Jacups S, McGough K, McDonald M, Currie BJ,. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia's Northern Territory. Heart Lung Circ. 2006; 15: 113-118.
22. Meira ZM, Goulart EM, Colosimo EA, Mota CC,. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005; 91: 1019-1022.
23. Figueroa FE, Fernandez MS, Valdes P, et al. Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease. Heart 2001; 85: 407-410.
24. Jaffe WM, Roche AH, Coverdale HA, McAlister HF, Ormiston JA, Greene ER,. Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease. Circulation 1988; 78: 267-275.
25. Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009; 120: 663-668.
26. Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am. J. Cardiol. 2010; 105: 1809-1814.
27. Marijon E, Ou P, Celermajer DS, et al. Echocardiographic screening for rheumatic heart disease. Bull. World Health Organ. 2008; 86: 84.
28. Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat. Rev. Cardiol. 2012; 9: 297-309.
29. Mincham CM, Mak DB, Plant AJ,. The quality of management of rheumatic fever/heart disease in the Kimberley. Aust. N. Z. J. Public Health 2002; 26: 417-420.
30. Eissa S, Lee R, Binns P, Garstone G, McDonald M,. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust. N. Z. J. Public Health 2005; 29: 521-525.
31. Kimberley Aboriginal Medical Services Council (KAMSC) and WA Country Health Service (WACHS) Kimberley. Kimberley Chronic Disease Therapeutic Protocols. 2007. Available from: http://resources.kamsc.org.au/downloads/cd-rhd. pdf [accessed 30 November 2012].
32. Queensland Health, Royal Flying Doctor Service of Australia (Queensland Section) and Apunipima Cape York Health Council. Chronic Disease Guidelines, 3rd edn. Cairns. 2010. Available from: http://www.health.qld.gov.au/cdg/docs/cdg- full-version.pdf [accessed 30 November 2011].
33. Heggie AD, Jacobs MR, Linz PE, Han DP, Kaplan EL, Boxerbaum B,. Prevalence and characteristics of pharyngeal group A beta-hemolytic streptococci in US navy recruits receiving benzathine penicillin prophylaxis. J. Infect. Dis. 1992; 166: 1006-1013.
34. Feinstein AR, Wood HF, Spagnuolo M, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. vii. Cardiac changes and sequelae. Ann. Intern. Med. 1964; 5: 87-123.
35. Ferrieri P,. Proceedings of the Jones criteria workshop. Circulation 2002; 106: 2521-2523.
36. Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J,. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med. J. Aust. 2006; 184: 514-517.
37. Brown A, Purton L, Schaeffer G, Wheaton W, White A,. Central Australian rheumatic heart disease control program-a report to the Commonwealth November 2002. In:, Krause V, ed. The Northern Territory Disease Control Bulletin. Casuarina, Northern Territory: Centre for Disease Control Northern Territory, 2003; 1, 8.
38. Paterson B, Ruben A, Nossar V,. School screening in remote Aboriginal communities-results of an evaluation. Aust. N. Z. J. Public Health 1998; 22: 685-689.
39. Michaud C, Rammohan R, Narula J,. Cost-effectiveness analysis of intervention strategies for reduction of the burden of rheumatic heart disease. In:, Narula J, Virmani R, Reddy K, Tandon R, eds. Rheumatic Fever. Washington, DC: American Registry of Pathology, 1999; 485-497.
40. You J, Hoy W, Zhao Y, Beaver C, Eagar K,. End-stage renal disease in the Northern Territory: current and future treatment costs. Med. J. Aust. 2002; 176: 461-465.
41. Day NE, Chamberlain J,. Screening for breast cancer: workshop report. Eur. J. Cancer Clin. Oncol. 1988; 24: 55-59.
42. Feldman W,. How serious are the adverse effects of screening? J. Gen. Intern. Med. 1990; 5: S50-53.
43. Brodersen J, McKenna SP, Doward LC, Thorsen H,. Measuring the psychosocial consequences of screening. Health Qual. Life Outcomes 2007; 5: 3.
44. McCann J, Stockton D, Godward S,. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res. 2002; 4: R11.
45. Gram IT, Lund E, Slenker SE,. Quality of life following a false positive mammogram. Br. J. Cancer 1990; 62: 1018-1022.
46. Stewart-Brown S, Farmer A,. Screening could seriously damage your health. BMJ 1997; 314: 533-534.
47. Sorenson JR, Levy HL, Mangione TW, Sepe SJ,. Parental response to repeat testing of infants with 'false-positive' results in a newborn screening program. Pediatrics 1984; 73: 183-187.
48. American Association For Cancer Research. False positive screening for cancer found to be frequent and costly. Science Daily 2004; 20 Dec. Available from: http://www.sciencedaily.com/releases/%202004/12/041220002224.htm [accessed 29 November 2011].
49. McCaffery KJ, Barratt AL,. Assessing psychosocial/quality of life outcomes in screening: how do we do it better? J. Epidemiol. Community Health 2004; 58: 968-970.